世界の在宅医療市場の規模は、2021年の1,989億ドルから、2026年までに2,982億ドルに達し、予測期間中のCAGRは8.4%と予想されます。高齢者人口の急増と慢性疾患の発生率の上昇、医療費の増加による費用対効果の高い医療提供の必要性の高まり、在宅医療機器の技術的進歩などがこの市場の推進要因です。
一方で、保険制度の変更、限定的な保険適用、患者の安全に関する懸念が、市場の成長をある程度抑制するでしょう。遠隔医療の普及および未開発の開発途上地域が、在宅医療市場のプレーヤーに大きな成長の機会をもたらします。
COVID-19のパンデミックは、在宅医療市場にさまざまな影響を及ぼします。ヘルスケア市場は製品とサービスで構成され、どちらも効果が異なります。 COVID-19は、血糖モニター、血圧経、パルスオキシメーター、体温計など、いくつかの在宅医療モニタリング製品にプラスの影響を与えます。
コロナウイルスのパンデミックによって在宅医療提供者は自宅で快適に脆弱な高齢者を治療できるため、在宅医療サービス業界は活況を呈していると考えられているかもしれません。しかし、実際は違います。多くの医療機関や医療提供者が事業の不振を報告しています。しかし、より多くの人々がCOVID-19から回復しているので、ビジネスは今後より速いペースで回復するため、在宅医療業界のこの不況はまもなく改善する見込みです。
目次
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 49)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
TABLE 1 EXCHANGE RATES UTILIZED FOR THE CONVERSION TO USD
1.5 LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY (Page No. - 54)
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Primary sources
2.1.2.2 Key data from primary sources
2.1.2.3 Key industry insights
2.1.2.4 Breakdown of primary interviews: By company type, designation, and region
2.2 MARKET SIZE ESTIMATION
FIGURE 2 REVENUE SHARE ANALYSIS ILLUSTRATION: F. HOFFMANN-LA ROCHE LTD.
FIGURE 3 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH (SUPPLY SIDE): COLLECTIVE REVENUE OF HOME HEALTHCARE PRODUCTS AND SERVICES
FIGURE 4 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 5 TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN & DATA TRIANGULATION
FIGURE 6 DATA TRIANGULATION METHODOLOGY
2.4 MARKET SHARE ANALYSIS
2.5 ASSUMPTIONS FOR THE STUDY
2.6 LIMITATIONS
2.6.1 METHODOLOGY-RELATED LIMITATIONS
2.7 RISK ASSESSMENT
TABLE 2 RISK ASSESSMENT: HOME HEALTHCARE MARKET
2.8 COVID-19 HEALTH ASSESSMENT
2.9 COVID-19 ECONOMIC ASSESSMENT
2.10 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO
FIGURE 7 CRITERIA IMPACTING THE GLOBAL ECONOMY
3 EXECUTIVE SUMMARY (Page No. - 68)
FIGURE 9 HOME HEALTHCARE MARKET, BY TYPE, 2021 VS. 2026 (USD BILLION)
FIGURE 10 HOME HEALTHCARE PRODUCTS MARKET, BY TYPE, 2021 VS. 2026 (USD BILLION)
FIGURE 11 HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2021 VS. 2026 (USD BILLION)
FIGURE 12 HOME HEALTHCARE MARKET, BY INDICATION, 2021 VS. 2026 (USD BILLION)
FIGURE 13 HOME HEALTHCARE MARKET, BY REGION, 2021 VS. 2026 (USD BILLION)
4 PREMIUM INSIGHTS (Page No. - 72)
4.1 HOME HEALTHCARE MARKET OVERVIEW
FIGURE 14 GROWING TARGET PATIENT POPULATION TO DRIVE MARKET GROWTH DURING THE FORECAST PERIOD
4.2 HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)
FIGURE 15 INHALERS SEGMENT TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
4.3 ASIA PACIFIC: HOME HEALTHCARE MARKET, BY MOBILITY CARE PRODUCT AND COUNTRY (2020)
FIGURE 16 WHEELCHAIRS DOMINATED THE ASIA PACIFIC HOME HEALTHCARE MARKET IN 2020
4.4 HOME HEALTHCARE MARKET, BY SERVICE, 2021-2026
FIGURE 17 INFUSION THERAPY SERVICES SEGMENT TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD (2021-2026)
4.5 HOME HEALTHCARE MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 18 JAPAN IS THE FASTEST-GROWING MARKET FOR HOME HEALTHCARE
5 MARKET OVERVIEW (Page No. - 76)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 19 HOME HEALTHCARE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Rapid growth in the elderly population and the rising incidence of chronic diseases
TABLE 3 OVERVIEW OF THE GERIATRIC POPULATION (MILLION)
FIGURE 20 GERIATRIC POPULATION, BY COUNTRY, 2010 VS. 2019 (% OF THE TOTAL POPULATION)
5.2.1.2 Rising R&D investments resulting in technologically advanced devices
TABLE 4 PRODUCT LAUNCHES
FIGURE 21 R&D EXPENDITURE (% OF TOTAL REVENUE), BY KEY PLAYER, 2019. VS 2020
5.2.1.3 Growing need for cost-effective healthcare delivery due to the increasing healthcare costs
5.2.1.4 Outbreak of the COVID-19 pandemic
5.2.2 RESTRAINTS
5.2.2.1 Changing reimbursement policies
5.2.2.2 Limited insurance coverage
5.2.2.3 Patient safety concerns
5.2.3 OPPORTUNITIES
5.2.3.1 Rising focus on telehealth
5.2.3.2 Untapped developing regions
5.2.3.3 Growing demand for home care therapeutic devices
5.2.3.4 Growing demand for home sleep apnea tests (HSATs)
5.2.3.5 Growing preference for home hemodialysis treatment
5.2.4 CHALLENGES
5.2.4.1 Shortage of homecare workers
5.3 RANGES/SCENARIOS
5.3.1 HOME HEALTHCARE MARKET
FIGURE 22 PESSIMISTIC SCENARIO
FIGURE 23 OPTIMISTIC SCENARIO
FIGURE 24 REALISTIC SCENARIO
5.4 REGULATORY ANALYSIS
TABLE 5 INDICATIVE LIST OF REGULATORY AUTHORITIES GOVERNING MEDICAL DEVICES
5.4.1 NORTH AMERICA
5.4.1.1 US
TABLE 6 CLASSIFICATION OF MEDICAL DEVICES BY THE US FDA
TABLE 7 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
FIGURE 25 PREMARKET NOTIFICATION: 510(K) APPROVAL FOR MEDICAL DEVICES
5.4.1.2 Canada
TABLE 8 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
FIGURE 26 APPROVAL PROCESS FOR MEDICAL DEVICES IN CANADA
5.4.2 EUROPE
FIGURE 27 CE APPROVAL PROCESS IN EUROPE FOR MEDICAL DEVICES
5.4.3 ASIA PACIFIC
5.4.3.1 Japan
TABLE 9 CLASSIFICATION OF MEDICAL DEVICES AND THE REVIEWING BODY IN JAPAN
5.4.3.2 China
TABLE 10 CHINA: CLASSIFICATION OF MEDICAL DEVICES
5.4.3.3 India
5.5 PORTER’S FIVE FORCES ANALYSIS: PULSE OXIMETERS MARKET
TABLE 11 PORTER’S FIVE FORCES ANALYSIS FOR THE PULSE OXIMETERS MARKET
5.5.1 THREAT OF NEW ENTRANTS
5.5.2 THREAT OF SUBSTITUTES
5.5.3 BARGAINING POWER OF SUPPLIERS
5.5.4 BARGAINING POWER OF BUYERS
5.5.5 INTENSITY OF COMPETITIVE RIVALRY
5.6 PORTER’S FIVE FORCES ANALYSIS: HEARING AIDS MARKET
TABLE 12 PORTER’S FIVE FORCES ANALYSIS: HEARING AIDS MARKET
5.6.1 THREAT OF NEW ENTRANTS
5.6.2 THREAT OF SUBSTITUTES
5.6.3 BARGAINING POWER OF BUYERS
5.6.4 BARGAINING POWER OF SUPPLIERS
5.6.5 DEGREE OF COMPETITION
5.7 TECHNOLOGY ANALYSIS
5.8 VALUE CHAIN ANALYSIS
FIGURE 28 VALUE CHAIN ANALYSIS: MAXIMUM VALUE IS ADDED DURING THE MANUFACTURING PHASE
5.9 SUPPLY CHAIN ANALYSIS
FIGURE 29 DISTRIBUTION—A STRATEGY PREFERRED BY PROMINENT COMPANIES
5.10 PATENT ANALYSIS
5.10.1 PATENT GRANTED TRENDS FOR HOME HEALTHCARE
FIGURE 30 PATENT GRANTED TRENDS, JANUARY 2011-NOVEMBER 2021
5.10.2 JURISDICTION AND TOP APPLICANT ANALYSIS
FIGURE 31 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR PULSE OXIMETER PATENTS, JANUARY 2011—NOVEMBER 2021
5.11 TRADE ANALYSIS
TABLE 13 IMPORT DATA FOR HS CODE 901890 - INSTRUMENTS AND APPLIANCES USED IN MEDICAL, SURGICAL, OR VETERINARY SCIENCES, BY COUNTRY, 2016-2020 (USD MILLION)
TABLE 14 EXPORT DATA FOR HS CODE 901890 - INSTRUMENTS AND APPLIANCES USED IN MEDICAL, SURGICAL, OR VETERINARY SCIENCES, BY COUNTRY, 2016-2020 (USD MILLION)
5.12 PRICING ANALYSIS
TABLE 15 PRICE RANGE FOR HOME CARE DEVICES, BY COUNTRY
TABLE 16 PRICES OF HEARING AIDS (2021)
5.13 ECOSYSTEM ANALYSIS
FIGURE 32 HOME HEALTHCARE DEVICES MARKET: ECOSYSTEM ANALYSIS
5.13.1 ROLE IN THE ECOSYSTEM
FIGURE 33 KEY PLAYERS IN THE HOME HEALTHCARE ECOSYSTEM
5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.14.1 REVENUE SHIFT & REVENUE POCKETS FOR HOME HEALTHCARE PRODUCT MANUFACTURERS OR SERVICE PROVIDERS
FIGURE 34 REVENUE SHIFT FOR HOME HEALTHCARE PRODUCTS AND SERVICES
TABLE 17 ADJACENT MARKETS AND THEIR CURRENT GROWTH
6 HOME HEALTHCARE MARKET, BY PRODUCT (Page No. - 113)
6.1 INTRODUCTION
TABLE 18 HOME HEALTHCARE PRODUCTS MARKET, BY TYPE, 2018-2020 (USD BILLION)
TABLE 19 HOME HEALTHCARE PRODUCTS MARKET, BY TYPE, 2021-2026 (USD BILLION)
TABLE 20 HOME HEALTHCARE PRODUCTS MARKET, BY REGION, 2018-2020 (USD BILLION)
TABLE 21 HOME HEALTHCARE PRODUCTS MARKET, BY REGION, 2021-2026 (USD BILLION)
6.2 THERAPEUTIC PRODUCTS
TABLE 22 HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2018-2020 (USD MILLION)
TABLE 23 HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 24 HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY REGION, 2018-2020 (USD BILLION)
TABLE 25 HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY REGION, 2021-2026 (USD BILLION)
6.2.1 DIALYSIS EQUIPMENT
6.2.1.1 Dialysis equipment has gained significance due to its improved clinical outcomes and better quality of life for patients
TABLE 26 DIALYSIS EQUIPMENT MARKET, BY REGION, 2018-2020 (USD MILLION)
TABLE 27 DIALYSIS EQUIPMENT MARKET, BY REGION, 2021-2026 (USD MILLION)
6.2.2 WOUND CARE PRODUCTS
6.2.2.1 Decreased cost and higher convenience and comfort of home care will ensure the growth of this segment
TABLE 28 WOUND CARE PRODUCTS MARKET, BY REGION, 2018-2020 (USD MILLION)
TABLE 29 WOUND CARE PRODUCTS MARKET, BY REGION, 2021-2026 (USD MILLION)
6.2.3 IV EQUIPMENT
6.2.3.1 IV equipment facilitates the delivery of antibiotics, fluid replacements, and chemotherapy with accuracy
TABLE 30 IV EQUIPMENT MARKET, BY REGION, 2018-2020 (USD MILLION)
TABLE 31 IV EQUIPMENT MARKET, BY REGION, 2021-2026 (USD MILLION)
6.2.4 SLEEP APNEA THERAPEUTIC DEVICES
6.2.4.1 Increasing patient preference for home-based sleep tests to fuel market growth
TABLE 32 SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY REGION, 2018-2020 (USD MILLION)
TABLE 33 SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY REGION, 2021-2026 (USD MILLION)
6.2.5 INSULIN DELIVERY DEVICES
6.2.5.1 High incidence of diabetes to drive the insulin delivery devices market
TABLE 34 INSULIN DELIVERY DEVICES MARKET, BY REGION, 2018-2020 (USD MILLION)
TABLE 35 INSULIN DELIVERY DEVICES MARKET, BY REGION, 2021-2026 (USD MILLION)
6.2.6 OXYGEN DELIVERY SYSTEMS
6.2.6.1 Technological advancements in oxygen therapy products to drive the market
TABLE 36 OXYGEN DELIVERY SYSTEMS MARKET, BY REGION, 2018-2020 (USD MILLION)
TABLE 37 OXYGEN DELIVERY SYSTEMS MARKET, BY REGION, 2021-2026 (USD MILLION)
6.2.7 INHALERS
6.2.7.1 High incidence of asthma is the major factor driving market growth
TABLE 38 INHALERS MARKET, BY REGION, 2018-2020 (USD MILLION)
TABLE 39 INHALERS MARKET, BY REGION, 2021-2026 (USD MILLION)
6.2.8 NEBULIZERS
6.2.8.1 Nebulizers are more effective as compared to oral dosages
TABLE 40 NEBULIZERS AVAILABLE IN THE MARKET
TABLE 41 NEBULIZERS MARKET, BY REGION, 2018-2020 (USD MILLION)
TABLE 42 NEBULIZERS MARKET, BY REGION, 2021-2026 (USD MILLION)
6.2.9 VENTILATORS
6.2.9.1 Home care ventilators are convenient and can be used in the comfort of the patient’s home
TABLE 43 VENTILATORS MARKET, BY REGION, 2018-2020 (USD MILLION)
TABLE 44 VENTILATORS MARKET, BY REGION, 2021-2026 (USD MILLION)
6.2.10 OTHER THERAPEUTIC PRODUCTS
TABLE 45 OTHER THERAPEUTIC PRODUCTS MARKET, BY REGION, 2018-2020 (USD MILLION)
TABLE 46 OTHER THERAPEUTIC PRODUCTS MARKET, BY REGION, 2021-2026 (USD MILLION)
6.3 TESTING, SCREENING, AND MONITORING PRODUCTS
TABLE 47 HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018-2020 (USD MILLION)
TABLE 48 HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 49 HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY REGION, 2018-2020 (USD BILLION)
TABLE 50 HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY REGION, 2021-2026 (USD BILLION)
6.3.1 BLOOD GLUCOSE MONITORS
6.3.1.1 Increasing prevalence of diabetes to drive the market growth
TABLE 51 BLOOD GLUCOSE MONITORS MARKET, BY REGION, 2018-2020 (USD MILLION)
TABLE 52 BLOOD GLUCOSE MONITORS MARKET, BY REGION, 2021-2026 (USD MILLION)
6.3.2 HEARING AIDS
6.3.2.1 High incidence of hearing impairment to drive the market
TABLE 53 GLOBAL NUMBER OF PEOPLE SUFFERING FROM HEARING LOSS IN 2020, BY AGE GROUP
TABLE 54 GLOBAL NUMBER OF PEOPLE SUFFERING FROM HEARING LOSS IN 2020, BY AGE GROUP (10-YEAR RANGE)
TABLE 55 GLOBAL NUMBER OF PEOPLE USING HEARING AID DEVICES, BY AGE GROUP
TABLE 56 HEARING AIDS MARKET, BY REGION, 2018-2020 (USD MILLION)
TABLE 57 HEARING AIDS MARKET, BY REGION, 2021-2026 (USD MILLION)
6.3.3 BLOOD PRESSURE MONITORS
6.3.3.1 Increasing number of patients with hypertension and amplified occurrence of cardiovascular diseases to drive the market growth
TABLE 58 BLOOD PRESSURE MONITORS MARKET, BY REGION, 2018-2020 (USD MILLION)
TABLE 59 BLOOD PRESSURE MONITORS MARKET, BY REGION, 2021-2026 (USD MILLION)
6.3.4 ECG/EKG DEVICES
6.3.4.1 High prevalence of cardiovascular diseases to drive the market
TABLE 60 ECG/EKG DEVICES MARKET, BY REGION, 2018-2020 (USD MILLION)
TABLE 61 ECG/EKG DEVICES MARKET, BY REGION, 2021-2026 (USD MILLION)
6.3.5 OVULATION & PREGNANCY TEST KITS
6.3.5.1 Privacy, convenience, accessibility, and quick results to drive the market for ovulation and pregnancy test kits
TABLE 62 OVULATION AND PREGNANCY TEST KITS MARKET, BY REGION, 2018-2020 (USD MILLION)
TABLE 63 OVULATION AND PREGNANCY TEST KITS MARKET, BY REGION, 2021-2026 (USD MILLION)
6.3.6 PULSE OXIMETERS
6.3.6.1 Pulse oximeters are used to measure oxygen saturation in the blood
TABLE 64 PULSE OXIMETERS OFFERED BY MAJOR PLAYERS
TABLE 65 PULSE OXIMETERS MARKET, BY REGION, 2018-2020 (USD MILLION)
TABLE 66 PULSE OXIMETERS MARKET, BY REGION, 2021-2026 (USD MILLION )
6.3.7 HEART RATE MONITORS
6.3.7.1 Ability to continuously monitor critical cardiac parameters to drive the demand for heart rate monitors
TABLE 67 HEART RATE MONITORS MARKET, BY REGION, 2018-2020 (USD MILLION)
TABLE 68 HEART RATE MONITORS MARKET, BY REGION, 2021-2026 (USD MILLION)
6.3.8 COAGULATION MONITORING PRODUCTS
6.3.8.1 Coagulation monitors are used for routine management of prothrombin time/international normalized ratio for safe and effective management
TABLE 69 COAGULATION MONITORING PRODUCTS MARKET, BY REGION, 2018-2020 (USD MILLION)
TABLE 70 COAGULATION MONITORING PRODUCTS MARKET, BY REGION, 2021-2026 (USD MILLION)
6.3.9 FETAL MONITORING DEVICES
6.3.9.1 Remote-based care by por TABLE fetal monitoring systems to drive market growth
TABLE 71 FETAL MONITORING DEVICES MARKET, BY REGION, 2018-2020 (USD MILLION)
TABLE 72 FETAL MONITORING DEVICES MARKET, BY REGION, 2021-2026 (USD MILLION)
6.3.10 HIV TEST KITS
6.3.10.1 Rising prevalence of HIV to drive the market
TABLE 73 HIV TEST KITS MARKET, BY REGION, 2018-2020 (USD MILLION)
TABLE 74 HIV TEST KITS MARKET, BY REGION, 2021-2026 (USD MILLION)
6.3.11 HOLTER & EVENT MONITORS
6.3.11.1 Rising awareness of preventive care and technological advancements to drive the market
TABLE 75 HOLTER & EVENT MONITORS MARKET, BY REGION, 2018-2020 (USD MILLION)
TABLE 76 HOLTER & EVENT MONITORS MARKET, BY REGION, 2021-2026 (USD MILLION)
6.3.12 TEMPERATURE MONITORING DEVICES
6.3.12.1 Technological innovations and increasing awareness on the use of temperature monitoring devices for personal care to drive market growth
TABLE 77 TEMPERATURE MONITORING DEVICES MARKET, BY REGION, 2018-2020 (USD MILLION)
TABLE 78 TEMPERATURE MONITORING DEVICES MARKET, BY REGION, 2021-2026 (USD MILLION)
6.3.13 CHOLESTEROL TESTING PRODUCTS
6.3.13.1 Rising obesity levels and the incidence of cardiovascular disorders are supporting market growth
TABLE 79 CHOLESTEROL MONITORING DEVICES MARKET, BY REGION, 2018-2020 (USD MILLION)
TABLE 80 CHOLESTEROL MONITORING DEVICES MARKET, BY REGION, 2021-2026 (USD MILLION)
6.3.14 DRUG & ALCOHOL TEST KITS
6.3.14.1 Rising consumption of drugs among teens to support market growth
TABLE 81 RECENT APPROVALS FOR DRUG AND ALCOHOL TESTING PRODUCTS AND SERVICES
TABLE 82 DRUG AND ALCOHOL TEST KITS MARKET, BY REGION, 2018-2020 (USD MILLION)
TABLE 83 DRUG AND ALCOHOL TEST KITS MARKET, BY REGION, 2021-2026 (USD MILLION)
6.3.15 PEAK FLOW METERS
6.3.15.1 Peak flow meters are used to monitor a person’s ability to breathe
TABLE 84 PEAK FLOW METERS MARKET, BY REGION, 2018-2020 (USD MILLION)
TABLE 85 PEAK FLOW METERS MARKET, BY REGION, 2021-2026 (USD MILLION)
6.3.16 COLON CANCER TEST KITS
6.3.16.1 High incidence of colorectal cancer to drive the market growth
TABLE 86 COLON CANCER TEST KITS MARKET, BY REGION, 2018-2020 (USD MILLION)
TABLE 87 COLON CANCER TEST KITS MARKET, BY REGION, 2021-2026 (USD MILLION)
6.3.17 ACTIVITY MONITORS & WRIST BANDS
6.3.17.1 Increasing prevalence of chronic diseases has resulted in a significant increase in the demand for activity monitors
TABLE 88 ACTIVITY MONITORS & WRISTBANDS MARKET, BY REGION, 2018-2020 (USD MILLION)
TABLE 89 ACTIVITY MONITORS & WRISTBANDS MARKET, BY REGION, 2021-2026 (USD MILLION)
6.3.18 EEG DEVICES
6.3.18.1 Emergence of epilepsy as a common neurological condition to drive the market for EEG devices
TABLE 90 EEG DEVICES MARKET, BY REGION, 2018-2020 (USD MILLION)
TABLE 91 EEG DEVICES MARKET, BY REGION, 2021-2026 (USD MILLION)
6.3.19 HOME SLEEP TESTING DEVICES
6.3.19.1 Cost-effectiveness of home-based sleep tests to fuel the growth of home sleep testing devices
TABLE 92 HOME SLEEP TESTING DEVICES MARKET, BY REGION, 2018-2020 (USD MILLION)
TABLE 93 HOME SLEEP TESTING DEVICES MARKET, BY REGION, 2021-2026 (USD MILLION)
6.3.20 HOME HEMOGLOBIN A1C TEST KITS
6.3.20.1 High incidence of diabetes to drive market growth
TABLE 94 HOME HEMOGLOBIN A1C TEST KITS MARKET, BY REGION, 2018-2020 (USD MILLION)
TABLE 95 HOME HEMOGLOBIN A1C TEST KITS MARKET, BY REGION, 2021-2026 (USD MILLION)
6.4 MOBILITY CARE PRODUCTS
TABLE 96 HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2018-2020 (USD MILLION)
TABLE 97 HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 98 HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY REGION, 2018-2020 (USD MILLION)
TABLE 99 HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY REGION, 2021-2026 (USD MILLION)
6.4.1 WHEELCHAIRS
6.4.1.1 Increased preference for wheelchairs to support market growth
TABLE 100 WHEELCHAIRS MARKET, BY REGION, 2018-2020 (USD MILLION)
TABLE 101 WHEELCHAIRS MARKET, BY REGION, 2021-2026 (USD MILLION)
6.4.2 MOBILITY SCOOTERS
6.4.2.1 Mobility scooters help users to travel long distances
TABLE 102 MOBILITY SCOOTERS MARKET, BY REGION, 2018-2020 (USD MILLION)
TABLE 103 MOBILITY SCOOTERS MARKET, BY REGION, 2021-2026 (USD MILLION)
6.4.3 WALKERS & ROLLATORS
6.4.3.1 Walkers are used by the disabled and the elderly for additional support while walking
TABLE 104 WALKERS AND ROLLATORS MARKET, BY REGION, 2018-2020 (USD MILLION)
TABLE 105 WALKERS AND ROLLATORS MARKET, BY REGION, 2021-2026 (USD MILLION)
6.4.4 CRUTCHES
6.4.4.1 Axilla crutches are the most preferred as they are easy to use and are often used by people who have a temporary injury
TABLE 106 CRUTCHES MARKET, BY REGION, 2018-2020 (USD MILLION)
TABLE 107 CRUTCHES MARKET, BY REGION, 2021-2026 (USD MILLION)
6.4.5 CANES
6.4.5.1 Canes are the most common assistive devices
TABLE 108 CANES MARKET, BY REGION, 2018-2020 (USD MILLION)
TABLE 109 CANES MARKET, BY REGION, 2021-2026 (USD MILLION)
7 HOME HEALTHCARE MARKET, BY SERVICE (Page No. - 171)
7.1 INTRODUCTION
TABLE 110 US: AVERAGE SENIOR CARE COST, BY TYPE AND DURATION, 2019
TABLE 111 HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2018-2020 (USD BILLION)
TABLE 112 HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2021-2026 (USD BILLION)
TABLE 113 HOME HEALTHCARE SERVICES MARKET, BY REGION, 2018-2020 (USD BILLION)
TABLE 114 HOME HEALTHCARE SERVICES MARKET, BY REGION, 2021-2026 (USD BILLION)
7.2 SKILLED NURSING
7.2.1 SKILLED NURSING SERVICES TO DOMINATE THE HOME HEALTHCARE SERVICES MARKET DURING THE FORECAST PERIOD
TABLE 115 SKILLED NURSING SERVICES MARKET, BY REGION, 2018-2020 (USD BILLION)
TABLE 116 SKILLED NURSING SERVICES MARKET, BY REGION, 2021-2026 (USD BILLION)
7.3 REHABILITATION THERAPY
7.3.1 REHABILITATION THERAPY SERVICES MAJORLY INCLUDE PHYSIOTHERAPY, OCCUPATIONAL THERAPY, AND SPEECH THERAPY
TABLE 117 REHABILITATION THERAPY SERVICES MARKET, BY REGION, 2018-2020 (USD BILLION)
TABLE 118 REHABILITATION THERAPY SERVICES MARKET, BY REGION, 2021-2026 (USD BILLION)
7.4 HOSPICE & PALLIATIVE CARE
7.4.1 RISING GERIATRIC POPULATION TO DRIVE HOSPICE & PALLIATIVE CARE SERVICES
TABLE 119 HOSPICE & PALLIATIVE CARE SERVICES MARKET, BY REGION, 2018-2020 (USD BILLION)
TABLE 120 HOSPICE & PALLIATIVE CARE SERVICES MARKET, BY REGION, 2021-2026 (USD BILLION)
7.5 UNSKILLED CARE
7.5.1 UNSKILLED CARE SERVICES ARE COST-EFFECTIVE AND OFFER COMFORT AND SECURITY TO PATIENTS
TABLE 121 UNSKILLED CARE SERVICES MARKET, BY REGION, 2018-2020 (USD BILLION)
TABLE 122 UNSKILLED CARE SERVICES MARKET, BY REGION, 2021-2026 (USD BILLION)
7.6 RESPIRATORY THERAPY
7.6.1 GROWING PREVALENCE OF RESPIRATORY DISORDERS TO DRIVE MARKET GROWTH
TABLE 123 RESPIRATORY THERAPY SERVICES MARKET, BY REGION, 2018-2020 (USD BILLION)
TABLE 124 RESPIRATORY THERAPY SERVICES MARKET, BY REGION, 2021-2026 (USD BILLION)
7.7 INFUSION THERAPY
7.7.1 HOME INFUSION IS A SAFE AND EFFECTIVE ALTERNATIVE TO IN-PATIENT CARE FOR VARIOUS DISEASE STATES AND THERAPIES
TABLE 125 INFUSION THERAPY SERVICES MARKET, BY REGION, 2018-2020 (USD MILLION)
TABLE 126 INFUSION THERAPY SERVICES MARKET, BY REGION, 2021-2026 (USD MILLION)
7.8 PREGNANCY CARE
7.8.1 PREGNANCY CARE SERVICES HELP EXPECTANT PARENTS TO MANAGE HIGH-RISK PREGNANCIES AND COMPLICATIONS
TABLE 127 PREGNANCY CARE SERVICES MARKET, BY REGION, 2018-2020 (USD MILLION)
TABLE 128 PREGNANCY CARE SERVICES MARKET, BY REGION, 2021-2026 (USD MILLION)
8 HOME HEALTHCARE MARKET, BY INDICATION (Page No. - 185)
8.1 INTRODUCTION
TABLE 129 HOME HEALTHCARE MARKET, BY INDICATION, 2018-2020 (USD BILLION)
TABLE 130 HOME HEALTHCARE MARKET, BY INDICATION, 2021-2026 (USD BILLION)
8.2 CANCER
8.2.1 HIGH PREVALENCE OF CANCER TO DRIVE MARKET GROWTH
TABLE 131 INCIDENCE OF CANCER, BY REGION, 2020 VS. 2030 VS. 2040 (MILLION)
TABLE 132 PROJECTED INCREASE IN THE GLOBAL NUMBER OF CANCER PATIENTS, 2015 VS. 2018 VS. 2035
TABLE 133 HOME HEALTHCARE MARKET FOR CANCER, BY REGION, 2018-2020 (USD BILLION)
TABLE 134 HOME HEALTHCARE MARKET FOR CANCER, BY REGION, 2021-2026 (USD BILLION)
8.3 RESPIRATORY DISEASES
8.3.1 RISING PREVALENCE OF RESPIRATORY DISEASES IS A KEY FACTOR DRIVING MARKET GROWTH
TABLE 135 INCIDENCE OF TB, 2019
TABLE 136 HOME HEALTHCARE MARKET FOR RESPIRATORY DISEASES, BY REGION, 2018-2020 (USD BILLION)
TABLE 137 HOME HEALTHCARE MARKET FOR RESPIRATORY DISEASES, BY REGION, 2021-2026 (USD BILLION)
8.4 MOVEMENT DISORDERS
8.4.1 AGING IS A RISK FACTOR FOR MOVEMENT DISORDERS
TABLE 138 HOME HEALTHCARE MARKET FOR MOVEMENT DISORDERS, BY REGION, 2018-2020 (USD BILLION)
TABLE 139 HOME HEALTHCARE MARKET FOR MOVEMENT DISORDERS, BY REGION, 2021-2026 (USD BILLION)
8.5 CARDIOVASCULAR DISEASES & HYPERTENSION
8.5.1 RISING INCIDENCE OF HYPERTENSION & CARDIOVASCULAR DISEASES TO DRIVE THE GROWTH OF THIS SEGMENT
TABLE 140 HOME HEALTHCARE MARKET FOR CARDIOVASCULAR DISEASES & HYPERTENSION, BY REGION, 2018-2020 (USD BILLION)
TABLE 141 HOME HEALTHCARE MARKET FOR CARDIOVASCULAR DISEASES & HYPERTENSION, BY REGION, 2021-2026 (USD BILLION)
8.6 PREGNANCY
8.6.1 RISING FOCUS ON BETTER CARE & MONITORING DURING PREGNANCY TO DRIVE MARKET GROWTH
TABLE 142 HOME HEALTHCARE MARKET FOR PREGNANCY, BY REGION, 2018-2020 (USD BILLION)
TABLE 143 HOME HEALTHCARE MARKET FOR PREGNANCY, BY REGION, 2021-2026 (USD BILLION)
8.7 WOUND CARE
8.7.1 GROWING NUMBER OF ROAD ACCIDENTS AND TRAUMA INJURIES TO DRIVE MARKET GROWTH
TABLE 144 HOME HEALTHCARE MARKET FOR WOUND CARE, BY REGION, 2018-2020 (USD BILLION)
TABLE 145 HOME HEALTHCARE MARKET FOR WOUND CARE, BY REGION, 2021-2026 (USD BILLION)
8.8 DIABETES
8.8.1 INCREASING INCIDENCE OF DIABETES TO PROPEL MARKET GROWTH
TABLE 146 HOME HEALTHCARE MARKET FOR DIABETES, BY REGION, 2018-2020 (USD BILLION)
TABLE 147 HOME HEALTHCARE MARKET FOR DIABETES, BY REGION, 2021-2026 (USD BILLION)
8.9 HEARING DISORDERS
8.9.1 PREVALENCE OF HEARING LOSS IS HIGHER IN THE AGING POPULATION
TABLE 148 GLOBAL INCIDENCE OF HEARING DISORDERS
TABLE 149 HOME HEALTHCARE MARKET FOR HEARING DISORDERS, BY REGION, 2018-2020 (USD BILLION)
TABLE 150 HOME HEALTHCARE MARKET FOR HEARING DISORDERS, BY REGION, 2021-2026 (USD BILLION)
8.10 OTHER INDICATIONS
TABLE 151 HOME HEALTHCARE MARKET FOR OTHER INDICATIONS, BY REGION, 2018-2020 (USD BILLION)
TABLE 152 HOME HEALTHCARE MARKET FOR OTHER INDICATIONS, BY REGION, 2021-2026 (USD BILLION)
9 HOME HEALTHCARE MARKET, BY REGION (Page No. - 201)
9.1 INTRODUCTION
TABLE 153 HOME HEALTHCARE MARKET, BY REGION, 2018-2020 (USD BILLION)
TABLE 154 HOME HEALTHCARE MARKET, BY REGION, 2021-2026 (USD BILLION)
9.2 NORTH AMERICA
FIGURE 35 NORTH AMERICA: HOME HEALTHCARE MARKET SNAPSHOT
TABLE 155 NORTH AMERICA: HOME HEALTHCARE MARKET, BY COUNTRY, 2018-2020 (USD BILLION)
TABLE 156 NORTH AMERICA: HOME HEALTHCARE MARKET, BY COUNTRY, 2021-2026 (USD BILLION)
TABLE 157 NORTH AMERICA: HOME HEALTHCARE MARKET, BY TYPE, 2018-2020 (USD BILLION)
TABLE 158 NORTH AMERICA: HOME HEALTHCARE MARKET, BY TYPE, 2021-2026 (USD BILLION)
TABLE 159 NORTH AMERICA: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE, 2018-2020 (USD MILLION)
TABLE 160 NORTH AMERICA: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 161 NORTH AMERICA: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018-2020 (USD MILLION)
TABLE 162 NORTH AMERICA: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 163 NORTH AMERICA: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2018-2020 (USD MILLION)
TABLE 164 NORTH AMERICA: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 165 NORTH AMERICA: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2018-2020 (USD MILLION)
TABLE 166 NORTH AMERICA: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 167 NORTH AMERICA: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2018-2020 (USD MILLION)
TABLE 168 NORTH AMERICA: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 169 NORTH AMERICA: HOME HEALTHCARE MARKET, BY INDICATION, 2018-2020 (USD MILLION)
TABLE 170 NORTH AMERICA: HOME HEALTHCARE MARKET, BY INDICATION, 2021-2026 (USD MILLION)
9.2.1 US
9.2.1.1 The US dominates the North American home healthcare market
TABLE 171 US: HOME HEALTHCARE MARKET, BY TYPE, 2018-2020 (USD BILLION)
TABLE 172 US: HOME HEALTHCARE MARKET, BY TYPE, 2021-2026 (USD BILLION)
TABLE 173 US: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE, 2018-2020 (USD MILLION)
TABLE 174 US: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 175 US: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018-2020 (USD MILLION)
TABLE 176 US: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 177 US: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2018-2020 (USD MILLION)
TABLE 178 US: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 179 US: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2018-2020 (USD MILLION)
TABLE 180 US: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 181 US: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2018-2020 (USD MILLION)
TABLE 182 US: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 183 US: HOME HEALTHCARE MARKET, BY INDICATION, 2018-2020 (USD MILLION)
TABLE 184 US: HOME HEALTHCARE MARKET, BY INDICATION, 2021-2026 (USD MILLION)
9.2.2 CANADA
9.2.2.1 Rising geriatric population in the country to drive market growth
TABLE 185 CANADA: HOME HEALTHCARE MARKET, BY TYPE, 2018-2020 (USD MILLION)
TABLE 186 CANADA: HOME HEALTHCARE MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 187 CANADA: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE, 2018-2020 (USD MILLION)
TABLE 188 CANADA: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 189 CANADA: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018-2020 (USD MILLION)
TABLE 190 CANADA: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 191 CANADA: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2018-2020 (USD MILLION)
TABLE 192 CANADA: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 193 CANADA: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2018-2020 (USD MILLION)
TABLE 194 CANADA: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 195 CANADA: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2018-2020 (USD MILLION)
TABLE 196 CANADA: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 197 CANADA: HOME HEALTHCARE MARKET, BY INDICATION, 2018-2020 (USD MILLION)
TABLE 198 CANADA: HOME HEALTHCARE MARKET, BY INDICATION, 2021-2026 (USD MILLION)
9.3 EUROPE
TABLE 199 EUROPE: PERCENTAGE OF POPULATION AGED 60 AND OVER, 2017 VS. 2050
TABLE 200 EUROPE: HOME HEALTHCARE MARKET, BY COUNTRY/REGION, 2018-2020 (USD BILLION)
TABLE 201 EUROPE: HOME HEALTHCARE MARKET, BY COUNTRY/REGION, 2021-2026 (USD BILLION)
TABLE 202 EUROPE: HOME HEALTHCARE MARKET, BY TYPE, 2018-2020 (USD MILLION)
TABLE 203 EUROPE: HOME HEALTHCARE MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 204 EUROPE: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE, 2018-2020 (USD MILLION)
TABLE 205 EUROPE: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 206 EUROPE: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018-2020 (USD MILLION)
TABLE 207 EUROPE: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 208 EUROPE: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2018-2020 (USD MILLION)
TABLE 209 EUROPE: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 210 EUROPE: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2018-2020 (USD MILLION)
TABLE 211 EUROPE: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 212 EUROPE: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2018-2020 (USD MILLION)
TABLE 213 EUROPE: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 214 EUROPE: HOME HEALTHCARE MARKET, BY INDICATION, 2018-2020 (USD MILLION)
TABLE 215 EUROPE: HOME HEALTHCARE MARKET, BY INDICATION, 2021-2026 (USD MILLION)
9.3.1 GERMANY
9.3.1.1 Germany to dominate the European home healthcare market
TABLE 216 GERMANY: KEY MACROINDICATORS
TABLE 217 GERMANY: HOME HEALTHCARE MARKET, BY TYPE, 2018-2020 (USD MILLION)
TABLE 218 GERMANY: HOME HEALTHCARE MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 219 GERMANY: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE, 2018-2020 (USD MILLION)
TABLE 220 GERMANY: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 221 GERMANY: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018-2020 (USD MILLION)
TABLE 222 GERMANY: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 223 GERMANY: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2018-2020 (USD MILLION)
TABLE 224 GERMANY: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 225 GERMANY: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2018-2020 (USD MILLION)
TABLE 226 GERMANY: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 227 GERMANY: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2018-2020 (USD MILLION)
TABLE 228 GERMANY: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 229 GERMANY: HOME HEALTHCARE MARKET, BY INDICATION, 2018-2020 (USD MILLION)
TABLE 230 GERMANY: HOME HEALTHCARE MARKET, BY INDICATION, 2021-2026 (USD MILLION)
9.3.2 FRANCE
9.3.2.1 Government support and initiatives taken by market players to drive the home healthcare market
TABLE 231 FRANCE: KEY INDICATORS
TABLE 232 FRANCE: HOME HEALTHCARE MARKET, BY TYPE, 2018-2020 (USD MILLION)
TABLE 233 FRANCE: HOME HEALTHCARE MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 234 FRANCE: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE, 2018-2020 (USD MILLION)
TABLE 235 FRANCE: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 236 FRANCE: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018-2020 (USD MILLION)
TABLE 237 FRANCE: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 238 FRANCE: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2018-2020 (USD MILLION)
TABLE 239 FRANCE: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 240 FRANCE: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2018-2020 (USD MILLION)
TABLE 241 FRANCE: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 242 FRANCE: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2018-2020 (USD MILLION)
TABLE 243 FRANCE: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 244 FRANCE: HOME HEALTHCARE MARKET, BY INDICATION, 2018-2020 (USD MILLION)
TABLE 245 FRANCE: HOME HEALTHCARE MARKET, BY INDICATION, 2021-2026 (USD MILLION)
9.3.3 UK
9.3.3.1 High burden of chronic diseases to drive the market in the country
TABLE 246 UK: KEY MACROINDICATORS
TABLE 247 UK: HOME HEALTHCARE MARKET, BY TYPE, 2018-2020 (USD MILLION)
TABLE 248 UK: HOME HEALTHCARE MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 249 UK: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE, 2018-2020 (USD MILLION)
TABLE 250 UK: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 251 UK: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018-2020 (USD MILLION)
TABLE 252 UK: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 253 UK: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2018-2020 (USD MILLION)
TABLE 254 UK: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 255 UK: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2018-2020 (USD MILLION)
TABLE 256 UK: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 257 UK: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2018-2020 (USD MILLION)
TABLE 258 UK: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 259 UK: HOME HEALTHCARE MARKET, BY INDICATION, 2018-2020 (USD MILLION)
TABLE 260 UK: HOME HEALTHCARE MARKET, BY INDICATION, 2021-2026 (USD MILLION)
9.3.4 ITALY
9.3.4.1 Rising geriatric population and the favorable government policy to drive the market in the country
TABLE 261 ITALY: KEY INDICATORS
TABLE 262 ITALY: HOME HEALTHCARE MARKET, BY TYPE, 2018-2020 (USD MILLION)
TABLE 263 ITALY: HOME HEALTHCARE MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 264 ITALY: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE, 2018-2020 (USD MILLION)
TABLE 265 ITALY: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 266 ITALY: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018-2020 (USD MILLION)
TABLE 267 ITALY: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 268 ITALY: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2018-2020 (USD MILLION)
TABLE 269 ITALY: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 270 ITALY: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2018-2020 (USD MILLION)
TABLE 271 ITALY: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 272 ITALY: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2018-2020 (USD MILLION)
TABLE 273 ITALY: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 274 ITALY: HOME HEALTHCARE MARKET, BY INDICATION, 2018-2020 (USD MILLION)
TABLE 275 ITALY: HOME HEALTHCARE MARKET, BY INDICATION, 2021-2026 (USD MILLION)
9.3.5 SPAIN
9.3.5.1 Rising geriatric population and the increasing incidence of chronic conditions to drive market growth
TABLE 276 SPAIN: KEY INDICATORS
TABLE 277 SPAIN: HOME HEALTHCARE MARKET, BY TYPE, 2018-2020 (USD MILLION)
TABLE 278 SPAIN: HOME HEALTHCARE MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 279 SPAIN: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE, 2018-2020 (USD MILLION)
TABLE 280 SPAIN: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 281 SPAIN: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018-2020 (USD MILLION)
TABLE 282 SPAIN: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 283 SPAIN: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2018-2020 (USD MILLION)
TABLE 284 SPAIN: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 285 SPAIN: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2018-2020 (USD MILLION)
TABLE 286 SPAIN: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 287 SPAIN: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2018-2020 (USD MILLION)
TABLE 288 SPAIN: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 289 SPAIN: HOME HEALTHCARE MARKET, BY INDICATION, 2018-2020 (USD MILLION)
TABLE 290 SPAIN: HOME HEALTHCARE MARKET, BY INDICATION, 2021-2026 (USD MILLION)
9.3.6 REST OF EUROPE
TABLE 291 ROE: HEALTHCARE EXPENDITURE, BY COUNTRY, 2010 VS. 2020 (% OF GDP)
TABLE 292 ROE: PERCENTAGE OF POPULATION AGED 60 AND OVER, 2017 VS. 2050
TABLE 293 ROE: HOME HEALTHCARE MARKET, BY TYPE, 2018-2020 (USD MILLION)
TABLE 294 ROE: HOME HEALTHCARE MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 295 ROE: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE, 2018-2020 (USD MILLION)
TABLE 296 ROE: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 297 ROE: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018-2020 (USD MILLION)
TABLE 298 ROE: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 299 ROE: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2018-2020 (USD MILLION)
TABLE 300 ROE: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 301 ROE: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2018-2020 (USD MILLION)
TABLE 302 ROE: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 303 ROE: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2018-2020 (USD MILLION)
TABLE 304 ROE: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 305 ROE: HOME HEALTHCARE MARKET, BY INDICATION, 2018-2020 (USD MILLION)
TABLE 306 ROE: HOME HEALTHCARE MARKET, BY INDICATION, 2021-2026 (USD MILLION)
9.4 ASIA PACIFIC
FIGURE 36 ASIA PACIFIC: HOME HEALTHCARE MARKET SNAPSHOT
TABLE 307 ASIA PACIFIC: HOME HEALTHCARE MARKET, BY COUNTRY, 2018-2020 (USD BILLION)
TABLE 308 ASIA PACIFIC: HOME HEALTHCARE MARKET, BY COUNTRY, 2021-2026 (USD BILLION)
TABLE 309 ASIA PACIFIC: HOME HEALTHCARE MARKET, BY TYPE, 2018-2020 (USD MILLION)
TABLE 310 ASIA PACIFIC: HOME HEALTHCARE MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 311 ASIA PACIFIC: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE, 2018-2020 (USD MILLION)
TABLE 312 ASIA PACIFIC: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 313 ASIA PACIFIC: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018-2020 (USD MILLION)
TABLE 314 ASIA PACIFIC: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 315 ASIA PACIFIC: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2018-2020 (USD MILLION)
TABLE 316 ASIA PACIFIC: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 317 ASIA PACIFIC: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2018-2020 (USD MILLION)
TABLE 318 ASIA PACIFIC: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 319 ASIA PACIFIC: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2018-2020 (USD MILLION)
TABLE 320 ASIA PACIFIC: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 321 ASIA PACIFIC: HOME HEALTHCARE MARKET, BY INDICATION, 2018-2020 (USD MILLION)
TABLE 322 ASIA PACIFIC: HOME HEALTHCARE MARKET, BY INDICATION, 2021-2026 (USD MILLION)
9.4.1 JAPAN
9.4.1.1 Growing geriatric population in the country to drive the home healthcare market
TABLE 323 JAPAN: KEY INDICATORS
TABLE 324 JAPAN: HOME HEALTHCARE MARKET, BY TYPE, 2018-2020 (USD MILLION)
TABLE 325 JAPAN: HOME HEALTHCARE MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 326 JAPAN: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE, 2018-2020 (USD MILLION)
TABLE 327 JAPAN: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 328 JAPAN: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018-2020 (USD MILLION)
TABLE 329 JAPAN: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 330 JAPAN: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2018-2020 (USD MILLION)
TABLE 331 JAPAN: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 332 JAPAN: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2018-2020 (USD MILLION)
TABLE 333 JAPAN: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 334 JAPAN: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2018-2020 (USD MILLION)
TABLE 335 JAPAN: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 336 JAPAN: HOME HEALTHCARE MARKET, BY INDICATION, 2018-2020 (USD MILLION)
TABLE 337 JAPAN: HOME HEALTHCARE MARKET, BY INDICATION, 2021-2026 (USD MILLION)
9.4.2 CHINA
9.4.2.1 Healthcare development and reforms will drive the market in the country
TABLE 338 CHINA: KEY INDICATORS
TABLE 339 CHINA: HOME HEALTHCARE MARKET, BY TYPE, 2018-2020 (USD MILLION)
TABLE 340 CHINA: HOME HEALTHCARE MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 341 CHINA: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE, 2018-2020 (USD MILLION)
TABLE 342 CHINA: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 343 CHINA: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018-2020 (USD MILLION)
TABLE 344 CHINA: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 345 CHINA: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2018-2020 (USD MILLION)
TABLE 346 CHINA: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 347 CHINA: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2018-2020 (USD MILLION)
TABLE 348 CHINA: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 349 CHINA: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2018-2020 (USD MILLION)
TABLE 350 CHINA: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 351 CHINA: HOME HEALTHCARE MARKET, BY INDICATION, 2018-2020 (USD MILLION)
TABLE 352 CHINA: HOME HEALTHCARE MARKET, BY INDICATION, 2021-2026 (USD MILLION)
9.4.3 INDIA
9.4.3.1 Increasing target patient population to drive the market in the country
TABLE 353 INDIA: KEY INDICATORS
TABLE 354 INDIA: HOME HEALTHCARE MARKET, BY TYPE, 2018-2020 (USD MILLION)
TABLE 355 INDIA: HOME HEALTHCARE MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 356 INDIA: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE, 2018-2020 (USD MILLION)
TABLE 357 INDIA: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 358 INDIA: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018-2020 (USD MILLION)
TABLE 359 INDIA: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 360 INDIA: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2018-2020 (USD MILLION)
TABLE 361 INDIA: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 362 INDIA: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2018-2020 (USD MILLION)
TABLE 363 INDIA: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 364 INDIA: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2018-2020 (USD MILLION)
TABLE 365 INDIA: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 366 INDIA: HOME HEALTHCARE MARKET, BY INDICATION, 2018-2020 (USD MILLION)
TABLE 367 INDIA: HOME HEALTHCARE MARKET, BY INDICATION, 2021-2026 (USD MILLION)
9.4.4 REST OF ASIA PACIFIC
TABLE 368 ROAPAC: HOME HEALTHCARE MARKET, BY TYPE, 2018-2020 (USD MILLION)
TABLE 369 ROAPAC: HOME HEALTHCARE MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 370 ROAPAC: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE, 2018-2020 (USD MILLION)
TABLE 371 ROAPAC: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 372 ROAPAC: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018-2020 (USD MILLION)
TABLE 373 ROAPAC: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 374 ROAPAC: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2018-2020 (USD MILLION)
TABLE 375 ROAPAC: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 376 ROAPAC: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2018-2020 (USD MILLION)
TABLE 377 ROAPAC: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 378 ROAPAC: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2018-2020 (USD MILLION)
TABLE 379 ROAPAC: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 380 ROAPAC: HOME HEALTHCARE MARKET, BY INDICATION, 2018-2020 (USD MILLION)
TABLE 381 ROAPAC: HOME HEALTHCARE MARKET, BY INDICATION, 2021-2026 (USD MILLION)
9.5 REST OF THE WORLD
TABLE 382 MEXICO: KEY INDICATORS
TABLE 383 BRAZIL: KEY INDICATORS
TABLE 384 ROW: HOME HEALTHCARE MARKET, BY TYPE, 2018-2020 (USD MILLION)
TABLE 385 ROW: HOME HEALTHCARE MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 386 ROW: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE, 2018-2020 (USD MILLION)
TABLE 387 ROW: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 388 ROW: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018-2020 (USD MILLION)
TABLE 389 ROW: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 390 ROW: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2018-2020 (USD MILLION)
TABLE 391 ROW: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 392 ROW: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2018-2020 (USD MILLION)
TABLE 393 ROW: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 394 ROW: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2018-2020 (USD MILLION)
TABLE 395 ROW: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2021-2026 (USD MILLION)
TABLE 396 ROW: HOME HEALTHCARE MARKET, BY INDICATION, 2018-2020 (USD MILLION)
TABLE 397 ROW: HOME HEALTHCARE MARKET, BY INDICATION, 2021-2026 (USD MILLION)
10 COMPETITIVE LANDSCAPE (Page No. - 339)
10.1 OVERVIEW
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
TABLE 398 OVERVIEW OF THE STRATEGIES ADOPTED BY KEY PLAYERS IN THE HOME HEALTHCARE MARKET
10.3 MARKET SHARE ANALYSIS, 2020
FIGURE 37 SLEEP APNEA DEVICES MARKET SHARE ANALYSIS, BY KEY PLAYER, 2020
FIGURE 38 HEARING AIDS MARKET SHARE, BY KEY PLAYER, 2020
10.4 COMPETITIVE LEADERSHIP MAPPING
10.4.1 STARS
10.4.2 EMERGING LEADERS
10.4.3 PERVASIVE PLAYERS
10.4.4 PARTICIPANTS
FIGURE 39 HOME HEALTHCARE MARKET: COMPETITIVE LEADERSHIP MAPPING (2020)
10.5 COMPETITIVE LEADERSHIP MAPPING FOR SMES/START-UPS
10.5.1 PROGRESSIVE COMPANIES
10.5.2 STARTING BLOCKS
10.5.3 RESPONSIVE COMPANIES
10.5.4 DYNAMIC COMPANIES
FIGURE 40 HOME HEALTHCARE MARKET: COMPETITIVE LEADERSHIP MAPPING FOR SMES & START-UPS (2020)
10.6 COMPANY FOOTPRINT
TABLE 399 COMPANY FOOTPRINT
TABLE 400 COMPANY PRODUCT FOOTPRINT
TABLE 401 COMPANY REGIONAL FOOTPRINT
10.7 COMPETITIVE SCENARIO
10.7.1 PRODUCT LAUNCHES & APPROVALS
TABLE 402 KEY PRODUCT LAUNCHES & APPROVALS, JANUARY 2018-OCTOBER 2021
10.7.2 DEALS
TABLE 403 KEY DEALS, JANUARY 2018-OCTOBER 2021
10.7.3 OTHER DEVELOPMENTS
TABLE 404 OTHER KEY DEVELOPMENTS, JANUARY 2018-OCTOBER 2021
11 COMPANY PROFILES (Page No. - 359)
11.1 KEY PLAYERS
(Business overview, Products offered, Recent developments, MnM view, Key strengths/right to win, Strategic choices made, and Weaknesses and competitive threats)*
11.1.1 FRESENIUS SE & CO. KGAA
TABLE 405 FRESENIUS SE & CO. KGAA: BUSINESS OVERVIEW
FIGURE 41 FRESENIUS SE & CO. KGAA: COMPANY SNAPSHOT (2020)
11.1.2 LINDE PLC
TABLE 406 LINDE PLC: BUSINESS OVERVIEW
FIGURE 42 LINDE PLC: COMPANY SNAPSHOT (2020)
11.1.3 F. HOFFMANN-LA ROCHE LTD.
TABLE 407 F. HOFFMANN-LA ROCHE LTD.: BUSINESS OVERVIEW
FIGURE 43 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2020)
11.1.4 A&D COMPANY, LIMITED
TABLE 408 A&D COMPANY, LIMITED: BUSINESS OVERVIEW
FIGURE 44 A&D COMPANY, LIMITED: COMPANY SNAPSHOT (2020)
11.1.5 BAYADA HOME HEALTH CARE
TABLE 409 BAYADA HOME HEALTH CARE: BUSINESS OVERVIEW
11.1.6 INVACARE CORPORATION
TABLE 410 INVACARE CORPORATION: BUSINESS OVERVIEW
FIGURE 45 INVACARE CORPORATION: COMPANY SNAPSHOT (2020)
11.1.7 ABBOTT
TABLE 411 ABBOTT: BUSINESS OVERVIEW
FIGURE 46 ABBOTT: COMPANY SNAPSHOT (2020)
11.1.8 AMEDISYS
TABLE 412 AMEDISYS: BUSINESS OVERVIEW
FIGURE 47 AMEDISYS: COMPANY SNAPSHOT (2020)
11.1.9 RESMED
TABLE 413 RESMED: BUSINESS OVERVIEW
FIGURE 48 RESMED: COMPANY SNAPSHOT (2020)
11.1.10 LHC GROUP, INC.
TABLE 414 LHC GROUP, INC.: BUSINESS OVERVIEW
FIGURE 49 LHC GROUP, INC.: COMPANY SNAPSHOT (2020)
11.1.11 OMRON CORPORATION
TABLE 415 OMRON CORPORATION: BUSINESS OVERVIEW
FIGURE 50 OMRON CORPORATION: COMPANY SNAPSHOT (2020)
11.1.12 KONINKLIJKE PHILIPS N.V.
TABLE 416 KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW
FIGURE 51 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2020)
11.1.13 GE HEALTHCARE (SUBSIDIARY OF GENERAL ELECTRIC COMPANY)
TABLE 417 GENERAL HEALTHCARE: BUSINESS OVERVIEW
FIGURE 52 GENERAL HEALTHCARE SNAPSHOT: COMPANY SNAPSHOT (2020)
11.1.14 DRIVE DEVILBISS HEALTHCARE
TABLE 418 DRIVE DEVILBISS HEALTHCARE: BUSINESS OVERVIEW
11.1.15 HAMILTON MEDICAL
TABLE 419 HAMILTON MEDICAL: BUSINESS OVERVIEW
11.2 OTHER PLAYERS
11.2.1 SUNRISE MEDICAL
11.2.2 ROMA MEDICAL
11.2.3 CAREMAX REHABILITATION EQUIPMENT CO., LTD.
11.2.4 VITALOGRAPH
11.2.5 ADVITA PFLEGEDIENST GMBH
11.2.6 RENAFAN GMBH
11.2.7 ADMR
11.2.8 APEX MEDICAL CORP.
11.2.9 CONTEC MEDICAL SYSTEMS CO., LTD.
11.2.10 LÖWENSTEIN MEDICAL TECHNOLOGY GMBH + CO. KG.
*Details on Business overview, Products offered, Recent developments, MnM view, Key strengths/right to win, Strategic choices made, and Weaknesses and competitive threats might not be captured in case of unlisted companies.
12 APPENDIX (Page No. - 428)
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 AVAILABLE CUSTOMIZATIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS